May 16, 2023 / 03:00PM GMT
Unidentified Analyst
Excellent. So good morning, everyone, and welcome to the second day of the JMP Securities Life Science Conference. It's my pleasure to introduce Kura Oncology, a physician-based biopharmaceutical company presenting for the company's Troy Wilson, President and CEO. Welcome Troy.
Troy Wilson - Kura Oncology, Inc. - President & CEO
Thank you.
Unidentified Analyst
As I've said to many other companies who get on the stage with me here, I don't know who's in the audience and I don't know who's hitting the replay button, whether they know the Kura story or not. If you could, in three to five minutes, just give us an overview of Kura Oncology.
Troy Wilson - Kura Oncology, Inc. - President & CEO
Sure. Yeah. So thank you for the invitation to come to New York and to attend the conference and to give an overview and answer questions. So as the name would suggest, at Kura Oncology, we're focused on the development of targeted therapies for the treatment of cancer, both solid
Kura Oncology Inc at JMP Securities Life Sciences Conference Transcript
May 16, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers